BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2013

Jun 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2013-06-03

Reporting Person: Ajer Jeffrey Robert (SVP, Chief Commercial Of)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-03	Common Stock	S	493	$58.3436	Disposed	14880	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 plan executed on December 11, 2012.

F2: The price in Column 4 is a weighted average price. The prices actually received ranged from $57.31 to $61.42. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.